Long-term efficacy and safety of YAG laser vitreolysis for vision degrading myodesopsia
AIM: To assess the long-term efficacy and safety of yttrium-aluminum garnet (YAG) laser vitreolysis for vision degrading myodesopsia (VDM) caused by posterior vitreous detachment (PVD). METHODS: This retrospective study reviewed VDM patients of PVD type undergoing YAG laser vitreolysis. The baseline...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2023-11-01
|
| Series: | International Journal of Ophthalmology |
| Subjects: | |
| Online Access: | http://ies.ijo.cn/en_publish/2023/11/20231110.pdf |
| _version_ | 1827784406191833088 |
|---|---|
| author | Tie-Zhu Lin Cheng Shi Xing Yang Emmanuel Eric Pazo Yan-Nian Hui Li-Jun Shen |
| author_facet | Tie-Zhu Lin Cheng Shi Xing Yang Emmanuel Eric Pazo Yan-Nian Hui Li-Jun Shen |
| author_sort | Tie-Zhu Lin |
| collection | DOAJ |
| description | AIM: To assess the long-term efficacy and safety of yttrium-aluminum garnet (YAG) laser vitreolysis for vision degrading myodesopsia (VDM) caused by posterior vitreous detachment (PVD). METHODS: This retrospective study reviewed VDM patients of PVD type undergoing YAG laser vitreolysis. The baseline demographic information, the patterns of floaters, the number of floaters, and the subjective improvement of floater sympotoms (ranging from 0 to 100%) from medical records were collected. Significant improvement was defined as a relief of floater symptoms of ≥50% at the final visit. The long-term efficacy and safety of YAG laser vitreolysis were analyzed. The risk factors linked to significant improvement of floater symptoms were defined using univariate and multivariate logistic regression analyses. RESULTS: The final analysis included 221 patients with VDM. The mean age of patients was 61.08±7.74y, and the mean length of follow-up was 21.38±5.61mo. Totally 57.01% of patients experienced a significant improvement in their floater symptoms after YAG laser therapy, and none of them developed delayed retinal abnormalities such as retinal tears or detachments. Age (OR=1.049, 95%CI=1.007-1.092, P=0.021) was identified as a significant risk factor for significant improvement in VDM. CONCLUSION: YAG laser vitreolysis is an effective and secure treatment for PVD-type VDM, and patients of advanced age are more likely to get favorable outcomes. |
| first_indexed | 2024-03-11T16:01:44Z |
| format | Article |
| id | doaj.art-2a29386d3b2b416395d253c51f1b6598 |
| institution | Directory Open Access Journal |
| issn | 2222-3959 2227-4898 |
| language | English |
| last_indexed | 2024-03-11T16:01:44Z |
| publishDate | 2023-11-01 |
| publisher | Press of International Journal of Ophthalmology (IJO PRESS) |
| record_format | Article |
| series | International Journal of Ophthalmology |
| spelling | doaj.art-2a29386d3b2b416395d253c51f1b65982023-10-25T06:50:11ZengPress of International Journal of Ophthalmology (IJO PRESS)International Journal of Ophthalmology2222-39592227-48982023-11-0116111800180510.18240/ijo.2023.11.1020231110Long-term efficacy and safety of YAG laser vitreolysis for vision degrading myodesopsiaTie-Zhu Lin0Cheng Shi1Xing Yang2Emmanuel Eric Pazo3Yan-Nian Hui4Li-Jun Shen5Li-Jun Shen. Zhejiang Provincial People's Hospital, Hangzhou 310000, Zhejiang Province, China. slj@mail.eye.ac.cn; Yan-Nian Hui. Xijing Hospital, Fourth Military Medical University, Xi'an 710032, Shaanxi Province, China. ynlhui@163.comHe Eye Specialist Hospital, Shenyang 110034, Liaoning Province, ChinaHe Eye Specialist Hospital, Shenyang 110034, Liaoning Province, ChinaHe Eye Specialist Hospital, Shenyang 110034, Liaoning Province, ChinaDepartment of Ophthalmology, Eye Institute of PLA, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, Shaanxi Province, ChinaDepartment of Ophthalmology, Zhejiang Provincial People's Hospital, Hangzhou 310000, Zhejiang Province, ChinaAIM: To assess the long-term efficacy and safety of yttrium-aluminum garnet (YAG) laser vitreolysis for vision degrading myodesopsia (VDM) caused by posterior vitreous detachment (PVD). METHODS: This retrospective study reviewed VDM patients of PVD type undergoing YAG laser vitreolysis. The baseline demographic information, the patterns of floaters, the number of floaters, and the subjective improvement of floater sympotoms (ranging from 0 to 100%) from medical records were collected. Significant improvement was defined as a relief of floater symptoms of ≥50% at the final visit. The long-term efficacy and safety of YAG laser vitreolysis were analyzed. The risk factors linked to significant improvement of floater symptoms were defined using univariate and multivariate logistic regression analyses. RESULTS: The final analysis included 221 patients with VDM. The mean age of patients was 61.08±7.74y, and the mean length of follow-up was 21.38±5.61mo. Totally 57.01% of patients experienced a significant improvement in their floater symptoms after YAG laser therapy, and none of them developed delayed retinal abnormalities such as retinal tears or detachments. Age (OR=1.049, 95%CI=1.007-1.092, P=0.021) was identified as a significant risk factor for significant improvement in VDM. CONCLUSION: YAG laser vitreolysis is an effective and secure treatment for PVD-type VDM, and patients of advanced age are more likely to get favorable outcomes.http://ies.ijo.cn/en_publish/2023/11/20231110.pdffloatersposterior vitreous detachmentyag laser vitreolysisrisk factorsvision degrading myodesopsia |
| spellingShingle | Tie-Zhu Lin Cheng Shi Xing Yang Emmanuel Eric Pazo Yan-Nian Hui Li-Jun Shen Long-term efficacy and safety of YAG laser vitreolysis for vision degrading myodesopsia International Journal of Ophthalmology floaters posterior vitreous detachment yag laser vitreolysis risk factors vision degrading myodesopsia |
| title | Long-term efficacy and safety of YAG laser vitreolysis for vision degrading myodesopsia |
| title_full | Long-term efficacy and safety of YAG laser vitreolysis for vision degrading myodesopsia |
| title_fullStr | Long-term efficacy and safety of YAG laser vitreolysis for vision degrading myodesopsia |
| title_full_unstemmed | Long-term efficacy and safety of YAG laser vitreolysis for vision degrading myodesopsia |
| title_short | Long-term efficacy and safety of YAG laser vitreolysis for vision degrading myodesopsia |
| title_sort | long term efficacy and safety of yag laser vitreolysis for vision degrading myodesopsia |
| topic | floaters posterior vitreous detachment yag laser vitreolysis risk factors vision degrading myodesopsia |
| url | http://ies.ijo.cn/en_publish/2023/11/20231110.pdf |
| work_keys_str_mv | AT tiezhulin longtermefficacyandsafetyofyaglaservitreolysisforvisiondegradingmyodesopsia AT chengshi longtermefficacyandsafetyofyaglaservitreolysisforvisiondegradingmyodesopsia AT xingyang longtermefficacyandsafetyofyaglaservitreolysisforvisiondegradingmyodesopsia AT emmanuelericpazo longtermefficacyandsafetyofyaglaservitreolysisforvisiondegradingmyodesopsia AT yannianhui longtermefficacyandsafetyofyaglaservitreolysisforvisiondegradingmyodesopsia AT lijunshen longtermefficacyandsafetyofyaglaservitreolysisforvisiondegradingmyodesopsia |